{
  "retracted": false,
  "timestamp": 1546560000000,
  "updates": [
    {
      "timestamp": 1570797621825,
      "identifier": {
        "doi": "10.1007/s40267-018-00596-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40267-018-0547-6"
  },
  "journal": "Drugs & Therapy Perspectives",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use"
}
